Presented by: Dr. Eric Wenzler, PharmD, BCPS, AAHIVP Assistant Professor
Bloodstream infections are a major cause of mortality and morbidity in hospitalized patients. Critical to improving time to effective antimicrobial therapy and clinical outcomes is the rapid identification of the causative pathogens. There are several molecular methods capable of rapidly identify microorganisms and associated resistance genes from positive blood cultures or directly from blood. Though many studies have shown the positive impact of molecular rapid diagnostic tests on patient outcomes, the greatest impact to patient care occurs when such a test is coupled with antimicrobial stewardship intervention.
This webinar will address the use of molecular rapid diagnostic tests for blood culture identification and the role of antimicrobial stewardship in the effective implementation and optimization of molecular rapid diagnostic tests in patients with bloodstream infections.
The views, opinions, and information expressed in the webinars posted on this website are solely those of the presenters and may not reflect the views or opinions of GenMark Diagnostics, Inc., its subsidiaries or affiliates ("GenMark"). GenMark takes no responsibility for, and makes no representations or warranties whatsoever, express or implied, with respect to the webinars or any information, content or materials presented therein.